Diabetic neuropathy

• Haisco Pharmaceutical Group

  Company1 trialPhase 122 people

• Ain Shams University

  2 trialsPhase 490 people

• Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

  1 trialPhase 468 people

• Peter Rossing

  1 trialPhase 2100 people

• Shifa International Hospital

  1 trialPhase 1170 people

• Washington State University

  1 trialPhase 110 people

• Hasanuddin University

  1 trial102 people

National Institute of Diabetes and Digestive and Kidney DiseasesUS$1.5m2 grants since 2022

• Schwann Cell Senescence and the Secretome Provide a Unifying Mechanism for the Onset and Progression of Diabetic Neuropathy

  National Institute of Diabetes and Digestive and Kidney DiseasesUniversity of Michigan at Ann ArborUS$779.3k2022–2031

• Unveiling skin-derived SIRT1 as a therapeutic target for diabetic neuropathy

  National Institute of Diabetes and Digestive and Kidney DiseasesJohns Hopkins UniversityUS$724k2026–2031